TherapeuticsMD (TXMD) Gross Margin (2011 - 2023)
TherapeuticsMD's (TXMD) quarterly Gross Margin came in at 107.04% in Q4 2023, up 704.0% YoY from 13.31% in Q4 2022, and up 207.04% on a QoQ basis from 100.0% in Q3 2023.
TherapeuticsMD (TXMD) Gross Margin (2011 - 2023) Analysis & Trends
TherapeuticsMD (TXMD) has 13 years of Gross Margin data on file, last reported at 107.04% in Q4 2023.
- Quarterly Gross Margin rose 704.0% year-over-year to 107.04% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 94.69% (down 2400.0% YoY) and the FY2023 annual result came in at 100.0%, up 200.0% from the prior year.
- Gross Margin rose to 107.04% in Q4 2023, from 100.0% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 2082.45% in Q1 2022 to a low of 100.0% in Q3 2023.
- A 5-year average of 185.15% and a median of 81.28% in 2019 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2022 — Gross Margin soared 200604 bps — and 2023, when it sank 198245 bps.
- Tracing TXMD's Gross Margin over 5 years: stood at 81.9% in 2019, then declined by 8 bps to 75.28% in 2020, then slipped by 1 bps to 74.64% in 2021, then surged by 34 bps to 100.0% in 2022, then advanced by 7 bps to 107.04% in 2023.
- The last three Gross Margin figures came in at 107.04% (Q4 2023), 100.0% (Q3 2023), and 100.0% (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.90 Bn | 40.24 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 32.51 Bn | 30.84 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.21 Bn | 19.55 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.97 Bn | 18.09 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.94 Bn | 11.41 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.17 Bn | 10.01 Bn | - | - |
| 10 | TherapeuticsMD | 23.96 Mn | 14.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 107.04% |
| Sep 30, 2023 | -100.00% |
| Jun 30, 2023 | 100.00% |
| Mar 31, 2023 | 100.00% |
| Dec 31, 2022 | 100.00% |
| Mar 31, 2022 | 2,082.45% |
| Dec 31, 2021 | 74.64% |
| Sep 30, 2021 | 79.21% |
| Jun 30, 2021 | 82.04% |
| Mar 31, 2021 | 76.41% |
| Dec 31, 2020 | 75.28% |
| Sep 30, 2020 | 83.05% |
| Jun 30, 2020 | 58.88% |
| Mar 31, 2020 | 77.84% |
| Dec 31, 2019 | 81.90% |
| Sep 30, 2019 | 93.91% |
| Jun 30, 2019 | 79.45% |
| Mar 31, 2019 | 80.67% |
| Dec 31, 2018 | 81.33% |
| Sep 30, 2018 | 79.88% |